Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 387 articles:
HTML format

Single Articles

    January 2021
  1. PENNER G, Lecocq S, Chopin A, Vedoya X, et al
    Aptamarker prediction of brain amyloid-beta status in cognitively normal individuals at risk for Alzheimer's disease.
    PLoS One. 2021;16:e0243902.
    PubMed     Abstract available

  2. VIDONI ED, Morris JK, Watts A, Perry M, et al
    Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer's: A 1-year randomized controlled trial.
    PLoS One. 2021;16:e0244893.
    PubMed     Abstract available

  3. MEGHDADI AH, Stevanovic Karic M, McConnell M, Rupp G, et al
    Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    PLoS One. 2021;16:e0244180.
    PubMed     Abstract available

  4. TOKUMITSU K, Yasui-Furukori N, Takeuchi J, Yachimori K, et al
    The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer's disease than MMSE alone.
    PLoS One. 2021;16:e0247427.
    PubMed     Abstract available

  5. CHELLAPPA RC, Lukose B, Rani P
    Correction: G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
    PLoS One. 2021;16:e0248252.
    PubMed     Abstract available

  6. VOIGT RM, Raeisi S, Yang J, Leurgans S, et al
    Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease.
    PLoS One. 2021;16:e0240342.
    PubMed     Abstract available

  7. GJERUM L, Andersen BB, Bruun M, Simonsen AH, et al
    Comparison of the clinical impact of 2-[18F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer's disease.
    PLoS One. 2021;16:e0248413.
    PubMed     Abstract available

  8. ZABEL P, Kaluzny JJ, Zabel K, Kaluzna M, et al
    Quantitative assessment of retinal thickness and vessel density using optical coherence tomography angiography in patients with Alzheimer's disease and glaucoma.
    PLoS One. 2021;16:e0248284.
    PubMed     Abstract available

  9. BAHADO-SINGH RO, Vishweswaraiah S, Aydas B, Yilmaz A, et al
    Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer's disease.
    PLoS One. 2021;16:e0248375.
    PubMed     Abstract available

  10. KIM D, Lee JH, Kim HY, Shin J, et al
    Correction: Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
    PLoS One. 2021;16:e0250194.
    PubMed     Abstract available

  11. TSUNEISHI M, Yamamoto T, Yamaguchi T, Kodama T, et al
    Association between number of teeth and Alzheimer's disease using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    PLoS One. 2021;16:e0251056.
    PubMed     Abstract available

  12. VELAZQUEZ M, Lee Y
    Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects.
    PLoS One. 2021;16:e0244773.
    PubMed     Abstract available

  13. MCCORMICK JW, Ammerman L, Chen G, Vogel PD, et al
    Transport of Alzheimer's associated amyloid-beta catalyzed by P-glycoprotein.
    PLoS One. 2021;16:e0250371.
    PubMed     Abstract available

  14. WEN LY, Wan L, Lai JN, Chen CS, et al
    Increased risk of Alzheimer's disease among patients with age-related macular degeneration: A nationwide population-based study.
    PLoS One. 2021;16:e0250440.
    PubMed     Abstract available

  15. STOJANOVIC F, Taktek M, Khieu NH, Huang J, et al
    NMR analysis of the correlation of metabolic changes in blood and cerebrospinal fluid in Alzheimer model male and female mice.
    PLoS One. 2021;16:e0250568.
    PubMed     Abstract available

  16. ZHENG C, Xu R
    Molecular subtyping of Alzheimer's disease with consensus non-negative matrix factorization.
    PLoS One. 2021;16:e0250278.
    PubMed     Abstract available

  17. JIANG X, Howard JH Jr, Rebeck GW, Turner RS, et al
    Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
    PLoS One. 2021;16:e0252958.
    PubMed     Abstract available

  18. ZHANG J, Zhang Y, Zou J, Cao F, et al
    A meta-analysis of cohort studies: Traumatic brain injury and risk of Alzheimer's Disease.
    PLoS One. 2021;16:e0253206.
    PubMed     Abstract available

  19. FUKUI K, Kimura S, Kato Y, Kohno M, et al
    Effects of far infrared light on Alzheimer's disease-transgenic mice.
    PLoS One. 2021;16:e0253320.
    PubMed     Abstract available

  20. WENG J, Zhao G, Weng L, Guan J, et al
    Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease.
    PLoS One. 2021;16:e0252969.
    PubMed     Abstract available

  21. MINICUCCI J, Alfond M, Demuro A, Gerberry D, et al
    Quantifying the dose-dependent impact of intracellular amyloid beta in a mathematical model of calcium regulation in xenopus oocyte.
    PLoS One. 2021;16:e0246116.
    PubMed     Abstract available

  22. TOPPING M, Kim J, Fletcher J
    Geographic variation in Alzheimer's disease mortality.
    PLoS One. 2021;16:e0254174.
    PubMed     Abstract available

  23. RHEW SH, Kravchenko J, Lyerly HK
    Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
    PLoS One. 2021;16:e0253253.
    PubMed     Abstract available

  24. LIBOWITZ MR, Wei K, Tran T, Chu K, et al
    Regional brain volumes relate to Alzheimer's disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study.
    PLoS One. 2021;16:e0254332.
    PubMed     Abstract available

    January 2020
  25. KWAK DE, Ko T, Koh HS, Ji YW, et al
    Alterations of aqueous humor Abeta levels in Abeta-infused and transgenic mouse models of Alzheimer disease.
    PLoS One. 2020;15:e0227618.
    PubMed     Abstract available

  26. WESTMAN G, Schoofs C, Ingelsson M, Jarhult JD, et al
    Torque teno virus viral load is related to age, CMV infection and HLA type but not to Alzheimer's disease.
    PLoS One. 2020;15:e0227670.
    PubMed     Abstract available

  27. HAIDER S, Liaquat L, Ahmad S, Batool Z, et al
    Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress.
    PLoS One. 2020;15:e0227631.
    PubMed     Abstract available

  28. DOWNER B, Al Snih S, Raji M, Chou LN, et al
    Healthcare utilization of Mexican-American Medicare beneficiaries with and without Alzheimer's disease and related dementias.
    PLoS One. 2020;15:e0227681.
    PubMed     Abstract available

  29. BLOCH K, Hornfeld SH, Dar S, Vanichkin A, et al
    Long-term effects of intracranial islet grafting on cognitive functioning in a rat metabolic model of sporadic Alzheimer's disease-like dementia.
    PLoS One. 2020;15:e0227879.
    PubMed     Abstract available

  30. MAO Y, Fisher DW, Yang S, Keszycki RM, et al
    Protein-protein interactions underlying the behavioral and psychological symptoms of dementia (BPSD) and Alzheimer's disease.
    PLoS One. 2020;15:e0226021.
    PubMed     Abstract available

  31. LIAO JY, Lee CT, Lin TY, Liu CM, et al
    Exploring prior diseases associated with incident late-onset Alzheimer's disease dementia.
    PLoS One. 2020;15:e0228172.
    PubMed     Abstract available

  32. SUN YQ, Richmond RC, Chen Y, Mai XM, et al
    Mixed evidence for the relationship between periodontitis and Alzheimer's disease: A bidirectional Mendelian randomization study.
    PLoS One. 2020;15:e0228206.
    PubMed     Abstract available

  33. LEE EG, Tulloch J, Chen S, Leong L, et al
    Redefining transcriptional regulation of the APOE gene and its association with Alzheimer's disease.
    PLoS One. 2020;15:e0227667.
    PubMed     Abstract available

  34. OH AJ, Amore G, Sultan W, Asanad S, et al
    Correction: Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer's disease.
    PLoS One. 2020;15:e0230061.
    PubMed     Abstract available

  35. WANG G, Kennedy RE, Goldberg TE, Fowler ME, et al
    Using practice effects for targeted trials or sub-group analysis in Alzheimer's disease: How practice effects predict change over time.
    PLoS One. 2020;15:e0228064.
    PubMed     Abstract available

  36. ORIMAYE SO, Goodkin K, Riaz OA, Salcedo JM, et al
    A machine learning-based linguistic battery for diagnosing mild cognitive impairment due to Alzheimer's disease.
    PLoS One. 2020;15:e0229460.
    PubMed     Abstract available

  37. BARTHOLD D, Joyce G, Diaz Brinton R, Wharton W, et al
    Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.
    PLoS One. 2020;15:e0229541.
    PubMed     Abstract available

  38. LI X, Yang X, Sun Z
    Alpha rhythm slowing in a modified thalamo-cortico-thalamic model related with Alzheimer's disease.
    PLoS One. 2020;15:e0229950.
    PubMed     Abstract available

  39. MARZBAN EN, Eldeib AM, Yassine IA, Kadah YM, et al
    Alzheimer's disease diagnosis from diffusion tensor images using convolutional neural networks.
    PLoS One. 2020;15:e0230409.
    PubMed     Abstract available

  40. ZHOU M, Xu R, Kaelber DC, Gurney ME, et al
    Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.
    PLoS One. 2020;15:e0229819.
    PubMed     Abstract available

  41. SHANG Y, Mishra A, Wang T, Wang Y, et al
    Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice.
    PLoS One. 2020;15:e0225392.
    PubMed     Abstract available

  42. IMAI H, Hirai T, Kumazawa R, Nakagawa S, et al
    Prevalence of and risk factors for adverse events in Alzheimer's patients receiving anti-dementia drugs in at-home care.
    PLoS One. 2020;15:e0231226.
    PubMed     Abstract available

  43. RHODIUS-MEESTER HFM, van Maurik IS, Koikkalainen J, Tolonen A, et al
    Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy.
    PLoS One. 2020;15:e0226784.
    PubMed     Abstract available

  44. CASTOR KJ, Shenoi S, Edminster SP, Tran T, et al
    Urine dicarboxylic acids change in pre-symptomatic Alzheimer's disease and reflect loss of energy capacity and hippocampal volume.
    PLoS One. 2020;15:e0231765.
    PubMed     Abstract available

  45. MOLINA M, Carmona I, Fuentes LJ, Plaza V, et al
    Enhanced learning and retention of medical information in Alzheimer's disease after differential outcomes training.
    PLoS One. 2020;15:e0231578.
    PubMed     Abstract available

  46. KANG MW, Park S, Lee S, Lee Y, et al
    Glomerular hyperfiltration is associated with dementia: A nationwide population-based study.
    PLoS One. 2020;15:e0228361.
    PubMed     Abstract available

  47. BURES J, Kvetina J, Radochova V, Tacheci I, et al
    The pharmacokinetic parameters and the effect of a single and repeated doses of memantine on gastric myoelectric activity in experimental pigs.
    PLoS One. 2020;15:e0227781.
    PubMed     Abstract available

  48. LIMBAD C, Oron TR, Alimirah F, Davalos AR, et al
    Astrocyte senescence promotes glutamate toxicity in cortical neurons.
    PLoS One. 2020;15:e0227887.
    PubMed     Abstract available

  49. ROMERO-ROSALES BL, Tamez-Pena JG, Nicolini H, Moreno-Trevino MG, et al
    Improving predictive models for Alzheimer's disease using GWAS data by incorporating misclassified samples modeling.
    PLoS One. 2020;15:e0232103.
    PubMed     Abstract available

  50. MUELLER KD, Norton D, Koscik RL, Morris MC, et al
    Self-reported health behaviors and longitudinal cognitive performance in late middle age: Results from the Wisconsin Registry for Alzheimer's Prevention.
    PLoS One. 2020;15:e0221985.
    PubMed     Abstract available

  51. BEACH TG, Adler CH, Zhang N, Serrano GE, et al
    Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia.
    PLoS One. 2020;15:e0231720.
    PubMed     Abstract available

  52. KIM JO, Lee SJ, Pyo JS
    Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: A meta-analysis.
    PLoS One. 2020;15:e0227820.
    PubMed     Abstract available

  53. ICHINOSE T, Murasawa H, Ishijima T, Okada S, et al
    Tyr-Trp administration facilitates brain norepinephrine metabolism and ameliorates a short-term memory deficit in a mouse model of Alzheimer's disease.
    PLoS One. 2020;15:e0232233.
    PubMed     Abstract available

  54. LARGENT EA, Harkins K, van Dyck CH, Hachey S, et al
    Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results.
    PLoS One. 2020;15:e0229137.
    PubMed     Abstract available

  55. HIN N, Newman M, Kaslin J, Douek AM, et al
    Accelerated brain aging towards transcriptional inversion in a zebrafish model of the K115fs mutation of human PSEN2.
    PLoS One. 2020;15:e0227258.
    PubMed     Abstract available

  56. SOTO-MERCADO V, Mendivil-Perez M, Velez-Pardo C, Lopera F, et al
    Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPbeta fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications.
    PLoS One. 2020;15:e0221669.
    PubMed     Abstract available

  57. TSAI CW, Tsai CF, Lin KH, Chen WJ, et al
    An investigation of the correlation between the S-glutathionylated GAPDH levels in blood and Alzheimer's disease progression.
    PLoS One. 2020;15:e0233289.
    PubMed     Abstract available

  58. SEKINE T, Buck A, Delso G, Kemp B, et al
    The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data.
    PLoS One. 2020;15:e0233886.
    PubMed     Abstract available

  59. PINEDA AM, Ramos FM, Betting LE, Campanharo ASLO, et al
    Quantile graphs for EEG-based diagnosis of Alzheimer's disease.
    PLoS One. 2020;15:e0231169.
    PubMed     Abstract available

  60. JONESCO DS, Karsdal MA, Henriksen K
    The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer's disease, other types of dementia and non-demented controls: A cross-sectional study.
    PLoS One. 2020;15:e0234632.
    PubMed     Abstract available

  61. XIE L, Varathan P, Nho K, Saykin AJ, et al
    Identification of functionally connected multi-omic biomarkers for Alzheimer's disease using modularity-constrained Lasso.
    PLoS One. 2020;15:e0234748.
    PubMed     Abstract available

  62. KIM B, Shin J, Kim Y, Choi JH, et al
    Destruction of ERP responses to deviance in an auditory oddball paradigm in amyloid infusion mice with memory deficits.
    PLoS One. 2020;15:e0230277.
    PubMed     Abstract available

  63. NEDDENS J, Daurer M, Flunkert S, Beutl K, et al
    Correlation of pyroglutamate amyloid beta and ptau Ser202/Thr205 levels in Alzheimer's disease and related murine models.
    PLoS One. 2020;15:e0235543.
    PubMed     Abstract available

  64. OVEISGHARAN S, Dawe RJ, Leurgans SE, Yu L, et al
    Total daily physical activity, brain pathologies, and parkinsonism in older adults.
    PLoS One. 2020;15:e0232404.
    PubMed     Abstract available

  65. CAMPOS CR, Kemble AM, Niewoehner J, Freskgard PO, et al
    Brain Shuttle Neprilysin reduces central Amyloid-beta levels.
    PLoS One. 2020;15:e0229850.
    PubMed     Abstract available

  66. FENG X, Guo J, Sigmon HC, Sloan RP, et al
    Brain regions vulnerable and resistant to aging without Alzheimer's disease.
    PLoS One. 2020;15:e0234255.
    PubMed     Abstract available

  67. BELTRAN JF, Wahba BM, Hose N, Shasha D, et al
    Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer's Disease Neuroimaging (ADNI) database.
    PLoS One. 2020;15:e0235663.
    PubMed     Abstract available

  68. TANAKA N, Okuda M, Nishigaki T, Tsuchiya N, et al
    Development of a brain-permeable peptide nanofiber that prevents aggregation of Alzheimer pathogenic proteins.
    PLoS One. 2020;15:e0235979.
    PubMed     Abstract available

  69. ASANAD S, Fantini M, Sultan W, Nassisi M, et al
    Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline.
    PLoS One. 2020;15:e0232785.
    PubMed     Abstract available

  70. JEONG J, Park HJ, Mun BR, Jang JK, et al
    JBPOS0101 regulates amyloid beta, tau, and glial cells in an Alzheimer's disease model.
    PLoS One. 2020;15:e0237153.
    PubMed     Abstract available

  71. MAVILIO A, Sisto D, Prete F, Guadalupi V, et al
    RE-PERG in early-onset Alzheimer's disease: A double-blind, electrophysiological pilot study.
    PLoS One. 2020;15:e0236568.
    PubMed     Abstract available

  72. SOS KE, Mayer MI, Takacs VT, Major A, et al
    Amyloid beta induces interneuron-specific changes in the hippocampus of APPNL-F mice.
    PLoS One. 2020;15:e0233700.
    PubMed     Abstract available

  73. DATE Y, Sugiyama D, Tabuchi H, Saito N, et al
    The utility of simple questions to evaluate cognitive impairment.
    PLoS One. 2020;15:e0233225.
    PubMed     Abstract available

  74. FALKENHAIN K, Ruiz-Uribe NE, Haft-Javaherian M, Ali M, et al
    A pilot study investigating the effects of voluntary exercise on capillary stalling and cerebral blood flow in the APP/PS1 mouse model of Alzheimer's disease.
    PLoS One. 2020;15:e0235691.
    PubMed     Abstract available

  75. CLARK RA, Nikolova N, McGeown WJ, Macdonald M, et al
    Eigenvector alignment: Assessing functional network changes in amnestic mild cognitive impairment and Alzheimer's disease.
    PLoS One. 2020;15:e0231294.
    PubMed     Abstract available

  76. LIU HC, Lin WC, Chiu MJ, Lu CH, et al
    Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology.
    PLoS One. 2020;15:e0234519.
    PubMed     Abstract available

  77. MAES T, Mascaro C, Rotllant D, Lufino MMP, et al
    Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations.
    PLoS One. 2020;15:e0233468.
    PubMed     Abstract available

  78. ZHANG S, Yang F, Wang Z, Qian X, et al
    Poor oral health conditions and cognitive decline: Studies in humans and rats.
    PLoS One. 2020;15:e0234659.
    PubMed     Abstract available

  79. TACKENBERG C, Kulic L, Nitsch RM
    Familial Alzheimer's disease mutations at position 22 of the amyloid beta-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    PLoS One. 2020;15:e0239584.
    PubMed     Abstract available

  80. COUGHLAN G, Puthusseryppady V, Lowry E, Gillings R, et al
    Test-retest reliability of spatial navigation in adults at-risk of Alzheimer's disease.
    PLoS One. 2020;15:e0239077.
    PubMed     Abstract available

  81. LOPEZ-DE-EGUILETA A, Lage C, Lopez-Garcia S, Pozueta A, et al
    Evaluation of choroidal thickness in prodromal Alzheimer's disease defined by amyloid PET.
    PLoS One. 2020;15:e0239484.
    PubMed     Abstract available

  82. WANG YY, Ma WW, Peng IF
    Screening of sleep assisting drug candidates with a Drosophila model.
    PLoS One. 2020;15:e0236318.
    PubMed     Abstract available

  83. BOUBAKRI A, Leri M, Bucciantini M, Najjaa H, et al
    Allium roseum L. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer's disease.
    PLoS One. 2020;15:e0223815.
    PubMed     Abstract available

  84. MITSUMORI R, Sakaguchi K, Shigemizu D, Mori T, et al
    Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer's disease patients.
    PLoS One. 2020;15:e0239196.
    PubMed     Abstract available

  85. RONCERO C, Nikelski J, Probst S, Fernandez A, et al
    The semantic storage loss score: An Algorithm for measuring an individual's level of semantic storage loss due to temporal lobe damage in neurodegenerative disease.
    PLoS One. 2020;15:e0235810.
    PubMed     Abstract available

  86. GUPTA A, Kennedy K, Perales-Puchalt J, Drew D, et al
    Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.
    PLoS One. 2020;15:e0239871.
    PubMed     Abstract available

  87. GAO Y, Sengupta A, Li M, Zu Z, et al
    Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease.
    PLoS One. 2020;15:e0240513.
    PubMed     Abstract available

  88. C RC, Lukose B, Rani P
    G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
    PLoS One. 2020;15:e0225487.
    PubMed     Abstract available

  89. KUEPER JK, Lizotte DJ, Montero-Odasso M, Speechley M, et al
    Cognition and motor function: The gait and cognition pooled index.
    PLoS One. 2020;15:e0238690.
    PubMed     Abstract available

  90. YAO T, Sweeney E, Nagorski J, Shulman JM, et al
    Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score.
    PLoS One. 2020;15:e0241707.
    PubMed     Abstract available

  91. YOKOSAWA K, Kimura K, Takase R, Murakami Y, et al
    Functional decline of the precuneus associated with mild cognitive impairment: Magnetoencephalographic observations.
    PLoS One. 2020;15:e0239577.
    PubMed     Abstract available

  92. AHMED S, Kim BC, Lee KH, Jung HY, et al
    Ensemble of ROI-based convolutional neural network classifiers for staging the Alzheimer disease spectrum from magnetic resonance imaging.
    PLoS One. 2020;15:e0242712.
    PubMed     Abstract available

  93. SEDGHIZADEH MJ, Hojjati H, Ezzatdoost K, Aghajan H, et al
    Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit.
    PLoS One. 2020;15:e0243535.
    PubMed     Abstract available

  94. OKUDA M, Fujita Y, Takada-Takatori Y, Sugimoto H, et al
    Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation.
    PLoS One. 2020;15:e0240378.
    PubMed     Abstract available

  95. GUYON A, Rousseau J, Lamothe G, Tremblay JP, et al
    The protective mutation A673T in amyloid precursor protein gene decreases Abeta peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.
    PLoS One. 2020;15:e0237122.
    PubMed     Abstract available

  96. KIM D, Lee JH, Kim HY, Shin J, et al
    Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
    PLoS One. 2020;15:e0243041.
    PubMed     Abstract available

  97. DENG Y, Wu S, Fan H
    Genome-wide pathway-based quantitative multiple phenotypes analysis.
    PLoS One. 2020;15:e0240910.
    PubMed     Abstract available

  98. LI QS, Tian C, Hinds D, Seabrook GR, et al
    The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship.
    PLoS One. 2020;15:e0241552.
    PubMed     Abstract available

  99. MENTINK LJ, Thomas J, Melis RJF, Olde Rikkert MGM, et al
    Home-EEG assessment of possible compensatory mechanisms for sleep disruption in highly irregular shift workers - The ANCHOR study.
    PLoS One. 2020;15:e0237622.
    PubMed     Abstract available

  100. GREEN EH, Kikis EA
    Determining the effects of nanoparticulate air pollution on proteostasis in Caenorhabditis elegans.
    PLoS One. 2020;15:e0243419.
    PubMed     Abstract available

  101. BORGSTEDT L, Blobner M, Musiol M, Bratke S, et al
    Neurotoxicity of different amyloid beta subspecies in mice and their interaction with isoflurane anaesthesia.
    PLoS One. 2020;15:e0242989.
    PubMed     Abstract available

    January 2019
  102. HUYNH MB, Ouidja MO, Chantepie S, Carpentier G, et al
    Glycosaminoglycans from Alzheimer's disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau.
    PLoS One. 2019;14:e0209573.
    PubMed     Abstract available

  103. HOLLNAGEL JO, Elzoheiry S, Gorgas K, Kins S, et al
    Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer's disease amyloidosis.
    PLoS One. 2019;14:e0209228.
    PubMed     Abstract available

  104. PERETTI DE, Vallez Garcia D, Reesink FE, van der Goot T, et al
    Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies.
    PLoS One. 2019;14:e0211000.
    PubMed     Abstract available

  105. BO Z, Wan Y, Meng SS, Lin T, et al
    The temporal trend and distribution characteristics in mortality of Alzheimer's disease and other forms of dementia in China: Based on the National Mortality Surveillance System (NMS) from 2009 to 2015.
    PLoS One. 2019;14:e0210621.
    PubMed     Abstract available

  106. CIMLER R, Maresova P, Kuhnova J, Kuca K, et al
    Predictions of Alzheimer's disease treatment and care costs in European countries.
    PLoS One. 2019;14:e0210958.
    PubMed     Abstract available

  107. CHO YY, Kwon OH, Park MK, Kim TW, et al
    Elevated cellular cholesterol in Familial Alzheimer's presenilin 1 mutation is associated with lipid raft localization of beta-amyloid precursor protein.
    PLoS One. 2019;14:e0210535.
    PubMed     Abstract available

  108. WEINSTEIN G, Davis-Plourde KL, Conner S, Himali JJ, et al
    Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts.
    PLoS One. 2019;14:e0212293.
    PubMed     Abstract available

  109. BEGIC E, Hadzidedic S, Kulaglic A, Ramic-Brkic B, et al
    SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients.
    PLoS One. 2019;14:e0212261.
    PubMed     Abstract available

  110. MOORE PJ, Lyons TJ, Gallacher J
    Random forest prediction of Alzheimer's disease using pairwise selection from time series data.
    PLoS One. 2019;14:e0211558.
    PubMed     Abstract available

  111. NGUYEN DT, Ryu S, Qureshi MNI, Choi M, et al
    Hybrid multivariate pattern analysis combined with extreme learning machine for Alzheimer's dementia diagnosis using multi-measure rs-fMRI spatial patterns.
    PLoS One. 2019;14:e0212582.
    PubMed     Abstract available

  112. CAILLAUD M, Guillard J, Richard D, Milin S, et al
    Trans epsilon viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model.
    PLoS One. 2019;14:e0212663.
    PubMed     Abstract available

  113. JUNAID M, Islam N, Hossain MK, Ullah MO, et al
    Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease.
    PLoS One. 2019;14:e0211935.
    PubMed     Abstract available

  114. MARTI-JUAN G, Sanroma G, Piella G
    Revealing heterogeneity of brain imaging phenotypes in Alzheimer's disease based on unsupervised clustering of blood marker profiles.
    PLoS One. 2019;14:e0211121.
    PubMed     Abstract available

  115. ORIMAYE SO, Wong JS, Wong CP
    Correction: Deep language space neural network for classifying mild cognitive impairment and Alzheimer-type dementia.
    PLoS One. 2019;14:e0214103.
    PubMed     Abstract available

  116. HAFT-JAVAHERIAN M, Fang L, Muse V, Schaffer CB, et al
    Deep convolutional neural networks for segmenting 3D in vivo multiphoton images of vasculature in Alzheimer disease mouse models.
    PLoS One. 2019;14:e0213539.
    PubMed     Abstract available

  117. KURIMOTO E, Nakashima M, Kimura H, Suzuki M, et al
    TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys.
    PLoS One. 2019;14:e0207969.
    PubMed     Abstract available

  118. PERETTI DE, Vallez Garcia D, Reesink FE, van der Goot T, et al
    Correction: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies.
    PLoS One. 2019;14:e0214187.
    PubMed     Abstract available

  119. NOMOTO S, Kinno R, Ochiai H, Kubota S, et al
    The relationship between thyroid function and cerebral blood flow in mild cognitive impairment and Alzheimer's disease.
    PLoS One. 2019;14:e0214676.
    PubMed     Abstract available

  120. ZHANG YS, Zhou N, Knoll BM, Samra S, et al
    Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer's Disease on optical coherence tomography angiography.
    PLoS One. 2019;14:e0214685.
    PubMed     Abstract available

  121. KIM JE, Park JJ, Lee MR, Choi JY, et al
    Constipation in Tg2576 mice model for Alzheimer's disease associated with dysregulation of mechanism involving the mAChR signaling pathway and ER stress response.
    PLoS One. 2019;14:e0215205.
    PubMed     Abstract available

  122. ROBY DA, Ruiz F, Kermath BA, Voorhees JR, et al
    Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-beta burden in a mouse model of Alzheimer's disease.
    PLoS One. 2019;14:e0215004.
    PubMed     Abstract available

  123. SOOBIAH C, Tadrous M, Knowles S, Blondal E, et al
    Variability in the validity and reliability of outcome measures identified in a systematic review to assess treatment efficacy of cognitive enhancers for Alzheimer's Dementia.
    PLoS One. 2019;14:e0215225.
    PubMed     Abstract available

  124. WESTFALL S, Lomis N, Prakash S
    A novel synbiotic delays Alzheimer's disease onset via combinatorial gut-brain-axis signaling in Drosophila melanogaster.
    PLoS One. 2019;14:e0214985.
    PubMed     Abstract available

  125. BAILLY L, David R, Chevrier R, Grebet J, et al
    Alzheimer's disease: Estimating its prevalence rate in a French geographical unit using the National Alzheimer Data Bank and national health insurance information systems.
    PLoS One. 2019;14:e0216221.
    PubMed     Abstract available

  126. JOVIC M, Loncarevic-Vasiljkovic N, Ivkovic S, Dinic J, et al
    Short-term fish oil supplementation applied in presymptomatic stage of Alzheimer's disease enhances microglial/macrophage barrier and prevents neuritic dystrophy in parietal cortex of 5xFAD mouse model.
    PLoS One. 2019;14:e0216726.
    PubMed     Abstract available

  127. LAFIRDEEN ASM, Cognat E, Sabia S, Hourregue C, et al
    Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of beta-amyloid peptide and tau.
    PLoS One. 2019;14:e0217026.
    PubMed     Abstract available

  128. NUNES A, Silva G, Duque C, Januario C, et al
    Retinal texture biomarkers may help to discriminate between Alzheimer's, Parkinson's, and healthy controls.
    PLoS One. 2019;14:e0218826.
    PubMed     Abstract available

  129. SCHULTZ N, Janelidze S, Byman E, Minthon L, et al
    Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer's disease.
    PLoS One. 2019;14:e0218561.
    PubMed     Abstract available

  130. MALEK-AHMADI M, Beach TG, Zamrini E, Adler CH, et al
    Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.
    PLoS One. 2019;14:e0217566.
    PubMed     Abstract available

  131. SONG YQ, Li Y, Zhang SL, Gao J, et al
    Proton pump inhibitor use does not increase dementia and Alzheimer's disease risk: An updated meta-analysis of published studies involving 642305 patients.
    PLoS One. 2019;14:e0219213.
    PubMed     Abstract available

  132. GODINI R, Pocock R, Fallahi H
    Caenorhabditis elegans hub genes that respond to amyloid beta are homologs of genes involved in human Alzheimer's disease.
    PLoS One. 2019;14:e0219486.
    PubMed     Abstract available

  133. BAKER E, Sims R, Leonenko G, Frizzati A, et al
    Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.
    PLoS One. 2019;14:e0218111.
    PubMed     Abstract available

  134. LEE JS, Lee Y, Andre EA, Lee KJ, et al
    Inhibition of Polo-like kinase 2 ameliorates pathogenesis in Alzheimer's disease model mice.
    PLoS One. 2019;14:e0219691.
    PubMed     Abstract available

  135. ROCHOY M, Bordet R, Gautier S, Chazard E, et al
    Factors associated with the onset of Alzheimer's disease: Data mining in the French nationwide discharge summary database between 2008 and 2014.
    PLoS One. 2019;14:e0220174.
    PubMed     Abstract available

  136. CHOI M, Youn H, Kim D, Lee S, et al
    Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia.
    PLoS One. 2019;14:e0220739.
    PubMed     Abstract available

  137. ERTUZUN T, Semerci A, Cakir ME, Ekmekcioglu A, et al
    Investigation of base excision repair gene variants in late-onset Alzheimer's disease.
    PLoS One. 2019;14:e0221362.
    PubMed     Abstract available

  138. SALOBRAR-GARCIA E, de Hoz R, Ramirez AI, Lopez-Cuenca I, et al
    Changes in visual function and retinal structure in the progression of Alzheimer's disease.
    PLoS One. 2019;14:e0220535.
    PubMed     Abstract available

  139. PICARD C, Poirier A, Belanger S, Labonte A, et al
    Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer's disease: A genetic and proteomic multi-cohort study.
    PLoS One. 2019;14:e0220254.
    PubMed     Abstract available

  140. MULLER EG, Edwin TH, Stokke C, Navelsaker SS, et al
    Amyloid-beta PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer s disease diagnosis in a memory clinic.
    PLoS One. 2019;14:e0221365.
    PubMed     Abstract available

  141. PRZYBYLSKA-KUC S, Zakrzewski M, Dybala A, Kicinski P, et al
    Obstructive sleep apnea may increase the risk of Alzheimer's disease.
    PLoS One. 2019;14:e0221255.
    PubMed     Abstract available

  142. MOREIRA HS, Costa AS, Machado A, Castro SL, et al
    Distinguishing mild cognitive impairment from healthy aging and Alzheimer's Disease: The contribution of the INECO Frontal Screening (IFS).
    PLoS One. 2019;14:e0221873.
    PubMed     Abstract available

  143. MOORE PJ, Lyons TJ, Gallacher J
    Using path signatures to predict a diagnosis of Alzheimer's disease.
    PLoS One. 2019;14:e0222212.
    PubMed     Abstract available

  144. BENITO-LEON J, Contador I, Vega S, Villarejo-Galende A, et al
    Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer's disease mortality.
    PLoS One. 2019;14:e0222505.
    PubMed     Abstract available

  145. Correction: Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia.
    PLoS One. 2019;14:e0222852.
    PubMed     Abstract available

  146. POTASHKIN JA, Bottero V, Santiago JA, Quinn JP, et al
    Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer's patients.
    PLoS One. 2019;14:e0222921.
    PubMed     Abstract available

  147. LIU Z, Wang W, Huang T, Wang C, et al
    CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer's disease.
    PLoS One. 2019;14:e0222757.
    PubMed     Abstract available

  148. GILLIGAN TM, Sibilia F, Farrell D, Lyons D, et al
    No relationship between fornix and cingulum degradation and within-network decreases in functional connectivity in prodromal Alzheimer's disease.
    PLoS One. 2019;14:e0222977.
    PubMed     Abstract available

  149. SMILNAK GJ, Deans JR, Doraiswamy PM, Stinnett S, et al
    Comorbidity of age-related macular degeneration with Alzheimer's disease: A histopathologic case-control study.
    PLoS One. 2019;14:e0223199.
    PubMed     Abstract available

  150. JOSEPH DJ, Liu C, Peng J, Liang G, et al
    Isoflurane mediated neuropathological and cognitive impairments in the triple transgenic Alzheimer's mouse model are associated with hippocampal synaptic deficits in an age-dependent manner.
    PLoS One. 2019;14:e0223509.
    PubMed     Abstract available

  151. SUDO FK, de Souza AS, Drummond C, Assuncao N, et al
    Inter-method and anatomical correlates of episodic memory tests in the Alzheimer's Disease spectrum.
    PLoS One. 2019;14:e0223731.
    PubMed     Abstract available

  152. MUNOZ-CABRERA JM, Sandoval-Hernandez AG, Nino A, Baez T, et al
    Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer s disease.
    PLoS One. 2019;14:e0223578.
    PubMed     Abstract available

  153. GUPTA Y, Lee KH, Choi KY, Lee JJ, et al
    Early diagnosis of Alzheimer's disease using combined features from voxel-based morphometry and cortical, subcortical, and hippocampus regions of MRI T1 brain images.
    PLoS One. 2019;14:e0222446.
    PubMed     Abstract available

  154. PARKER TD, Cash DM, Lane CAS, Lu K, et al
    Hippocampal subfield volumes and pre-clinical Alzheimer's disease in 408 cognitively normal adults born in 1946.
    PLoS One. 2019;14:e0224030.
    PubMed     Abstract available

  155. JANG HD, Park JS, Kim DW, Han K, et al
    Relationship between dementia and ankylosing spondylitis: A nationwide, population-based, retrospective longitudinal cohort study.
    PLoS One. 2019;14:e0210335.
    PubMed     Abstract available

  156. GOFRIT ON, Klein BY, Cohen IR, Ben-Hur T, et al
    Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
    PLoS One. 2019;14:e0224433.
    PubMed     Abstract available

  157. YOUSSIF KA, Haggag EG, Elshamy AM, Rabeh MA, et al
    Anti-Alzheimer potential, metabolomic profiling and molecular docking of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea aqueous extracts.
    PLoS One. 2019;14:e0223781.
    PubMed     Abstract available

  158. KIM JI, Kang BH
    Decreased retinal thickness in patients with Alzheimer's disease is correlated with disease severity.
    PLoS One. 2019;14:e0224180.
    PubMed     Abstract available

  159. DEMARSHALL C, Oh E, Kheirkhah R, Sieber F, et al
    Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients.
    PLoS One. 2019;14:e0225178.
    PubMed     Abstract available

  160. YANEZ LOPEZ M, Pardon MC, Baiker K, Prior M, et al
    Myoinositol CEST signal in animals with increased Iba-1 levels in response to an inflammatory challenge-Preliminary findings.
    PLoS One. 2019;14:e0212002.
    PubMed     Abstract available

  161. HUANG Q, Sun D, Zubair Hussain M, Liu Y, et al
    HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity.
    PLoS One. 2019;14:e0212648.
    PubMed     Abstract available

  162. CHO SJ, Yun SM, Jo C, Jeong J, et al
    Altered expression of Notch1 in Alzheimer's disease.
    PLoS One. 2019;14:e0224941.
    PubMed     Abstract available

  163. PANAYIOTOU E, Fella E, Andreou S, Papacharalambous R, et al
    C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Abeta amyloid and preserves memory in a mouse model of familial Alzheimer's disease.
    PLoS One. 2019;14:e0225417.
    PubMed     Abstract available

  164. PUNJABI A, Martersteck A, Wang Y, Parrish TB, et al
    Neuroimaging modality fusion in Alzheimer's classification using convolutional neural networks.
    PLoS One. 2019;14:e0225759.
    PubMed     Abstract available

  165. SILZER T, Barber R, Sun J, Pathak G, et al
    Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans.
    PLoS One. 2019;14:e0213527.
    PubMed     Abstract available

  166. PARK JE, Yun J, Kim SJ, Shim WH, et al
    Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer's disease differ according to disease severity and amyloid positivity.
    PLoS One. 2019;14:e0226265.
    PubMed     Abstract available

  167. OH AJ, Amore G, Sultan W, Asanad S, et al
    Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer's disease.
    PLoS One. 2019;14:e0226197.
    PubMed     Abstract available

  168. TOKUOKA SM, Kita Y, Shimizu T, Oda Y, et al
    Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease.
    PLoS One. 2019;14:e0226073.
    PubMed     Abstract available

  169. ELMER BM, Swanson KA, Bangari DS, Piepenhagen PA, et al
    Gene delivery of a modified antibody to Abeta reduces progression of murine Alzheimer's disease.
    PLoS One. 2019;14:e0226245.
    PubMed     Abstract available

  170. OZSAHIN I, Sekeroglu B, Mok GSP
    The use of back propagation neural networks and 18F-Florbetapir PET for early detection of Alzheimer's disease using Alzheimer's Disease Neuroimaging Initiative database.
    PLoS One. 2019;14:e0226577.
    PubMed     Abstract available

  171. IVASHKO-PACHIMA Y, Maor-Nof M, Gozes I
    NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
    PLoS One. 2019;14:e0213666.
    PubMed     Abstract available

  172. MCGRATH ER, Himali JJ, Levy D, Conner SC, et al
    Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.
    PLoS One. 2019;14:e0213321.
    PubMed     Abstract available

  173. GRANT MKO, Handoko M, Rozga M, Brinkmalm G, et al
    Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments.
    PLoS One. 2019;14:e0212815.
    PubMed     Abstract available

  174. DING X, Charnigo RJ, Schmitt FA, Kryscio RJ, et al
    Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI.
    PLoS One. 2019;14:e0212435.
    PubMed     Abstract available

  175. MONACO A, Amoroso N, Bellantuono L, Lella E, et al
    Shannon entropy approach reveals relevant genes in Alzheimer's disease.
    PLoS One. 2019;14:e0226190.
    PubMed     Abstract available

  176. ROYALL DR, Palmer RF
    Selection for depression-specific dementia cases with replication in two cohorts.
    PLoS One. 2019;14:e0216413.
    PubMed     Abstract available

  177. PATIL DN, Patil SA, Sistla S, Jadhav JP, et al
    Comparative biophysical characterization: A screening tool for acetylcholinesterase inhibitors.
    PLoS One. 2019;14:e0215291.
    PubMed     Abstract available

  178. ESQUERDA-CANALS G, Marti-Clua J, Villegas S
    Pharmacokinetic parameters and mechanism of action of an efficient anti-Abeta single chain antibody fragment.
    PLoS One. 2019;14:e0217793.
    PubMed     Abstract available

  179. SINNIGE T, Ciryam P, Casford S, Dobson CM, et al
    Expression of the amyloid-beta peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response.
    PLoS One. 2019;14:e0217746.
    PubMed     Abstract available

  180. HUANG YY, Chiu MJ, Yen RF, Tsai CL, et al
    An one-pot two-step automated synthesis of [18F]T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans.
    PLoS One. 2019;14:e0217384.
    PubMed     Abstract available

  181. ETO M, Hashimoto T, Shimizu T, Iwatsubo T, et al
    Characterization of the unique In Vitro effects of unsaturated fatty acids on the formation of amyloid beta fibrils.
    PLoS One. 2019;14:e0219465.
    PubMed     Abstract available

  182. CHEN JL, Moss WN, Spencer A, Zhang P, et al
    The RNA encoding the microtubule-associated protein tau has extensive structure that affects its biology.
    PLoS One. 2019;14:e0219210.
    PubMed     Abstract available

  183. HUANG CN, Wang CJ, Lin CL, Yen AT, et al
    Abelmoschus esculentus subfractions attenuate beta amyloid-induced neuron apoptosis by regulating DPP-4 with improving insulin resistance signals.
    PLoS One. 2019;14:e0217400.
    PubMed     Abstract available

  184. HOFFMAN JD, Yanckello LM, Chlipala G, Hammond TC, et al
    Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model.
    PLoS One. 2019;14:e0221828.
    PubMed     Abstract available

  185. MCAVOY KM, Rajamohamed Sait H, Marsh G, Peterson M, et al
    Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.
    PLoS One. 2019;14:e0220125.
    PubMed     Abstract available

  186. BUCHMAN AS, Yu L, Petyuk VA, Gaiteri C, et al
    Cognition may link cortical IGFBP5 levels with motor function in older adults.
    PLoS One. 2019;14:e0220968.
    PubMed     Abstract available

  187. HVIDSTEN L, Engedal K, Selbaek G, Wyller TB, et al
    Quality of life of family carers of persons with young-onset dementia: A Nordic two-year observational multicenter study.
    PLoS One. 2019;14:e0219859.
    PubMed     Abstract available

  188. UEKI M, Fujii M, Tamiya G
    Quick assessment for systematic test statistic inflation/deflation due to null model misspecifications in genome-wide environment interaction studies.
    PLoS One. 2019;14:e0219825.
    PubMed     Abstract available

  189. REES JMB, Wood AM, Dudbridge F, Burgess S, et al
    Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates.
    PLoS One. 2019;14:e0222362.
    PubMed     Abstract available

  190. CHAGANTI S, Welty VF, Taylor W, Albert K, et al
    Discovering novel disease comorbidities using electronic medical records.
    PLoS One. 2019;14:e0225495.
    PubMed     Abstract available

    January 2018
  191. DO K, Laing BT, Landry T, Bunner W, et al
    The effects of exercise on hypothalamic neurodegeneration of Alzheimer's disease mouse model.
    PLoS One. 2018;13:e0190205.
    PubMed     Abstract available

  192. MASTROENI D, Sekar S, Nolz J, Delvaux E, et al
    Correction: ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.
    PLoS One. 2018;13:e0191382.
    PubMed     Abstract available

  193. HAIGHT T, Bryan RN, Meirelles O, Tracy R, et al
    Associations of plasma clusterin and Alzheimer's disease-related MRI markers in adults at mid-life: The CARDIA Brain MRI sub-study.
    PLoS One. 2018;13:e0190478.
    PubMed     Abstract available

  194. HADJICHRYSANTHOU C, Ower AK, de Wolf F, Anderson RM, et al
    The development of a stochastic mathematical model of Alzheimer's disease to help improve the design of clinical trials of potential treatments.
    PLoS One. 2018;13:e0190615.
    PubMed     Abstract available

  195. LAD EM, Mukherjee D, Stinnett SS, Cousins SW, et al
    Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's disease.
    PLoS One. 2018;13:e0192646.
    PubMed     Abstract available

  196. DE LEON MJ, Pirraglia E, Osorio RS, Glodzik L, et al
    The nonlinear relationship between cerebrospinal fluid Abeta42 and tau in preclinical Alzheimer's disease.
    PLoS One. 2018;13:e0191240.
    PubMed     Abstract available

  197. YOU JC, Stephens GS, Fu CH, Zhang X, et al
    Genome-wide profiling reveals functional diversification of FosB gene targets in the hippocampus of an Alzheimer's disease mouse model.
    PLoS One. 2018;13:e0192508.
    PubMed     Abstract available

  198. JIANG H, Liu Y, Wei Y, Shi Y, et al
    Impaired retinal microcirculation in patients with Alzheimer's disease.
    PLoS One. 2018;13:e0192154.
    PubMed     Abstract available

  199. MOSCONI L, Berti V, Quinn C, McHugh P, et al
    Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.
    PLoS One. 2018;13:e0193314.
    PubMed     Abstract available

  200. TROMBETTA BA, Carlyle BC, Koenig AM, Shaw LM, et al
    The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.
    PLoS One. 2018;13:e0193707.
    PubMed     Abstract available

  201. VAN GIJSEL-BONNELLO M, Baranger K, Benech P, Rivera S, et al
    Correction: Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.
    PLoS One. 2018;13:e0194586.
    PubMed     Abstract available

  202. HOUMANI N, Vialatte F, Gallego-Jutgla E, Dreyfus G, et al
    Diagnosis of Alzheimer's disease with Electroencephalography in a differential framework.
    PLoS One. 2018;13:e0193607.
    PubMed     Abstract available

  203. WHITE MR, Kandel R, Hsieh IN, De Luna X, et al
    Critical role of C-terminal residues of the Alzheimer's associated beta-amyloid protein in mediating antiviral activity and modulating viral and bacterial interactions with neutrophils.
    PLoS One. 2018;13:e0194001.
    PubMed     Abstract available

  204. BI XA, Shu Q, Sun Q, Xu Q, et al
    Random support vector machine cluster analysis of resting-state fMRI in Alzheimer's disease.
    PLoS One. 2018;13:e0194479.
    PubMed     Abstract available

  205. KLAKOTSKAIA D, Agca C, Richardson RA, Stopa EG, et al
    Memory deficiency, cerebral amyloid angiopathy, and amyloid-beta plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.
    PLoS One. 2018;13:e0195469.
    PubMed     Abstract available

  206. STEPANOV A, Karelina T, Markevich N, Demin O, et al
    A mathematical model of multisite phosphorylation of tau protein.
    PLoS One. 2018;13:e0192519.
    PubMed     Abstract available

  207. BARRERA J, Subramanian S, Chiba-Falek O
    Probing the role of PPARgamma in the regulation of late-onset Alzheimer's disease-associated genes.
    PLoS One. 2018;13:e0196943.
    PubMed     Abstract available

  208. DENK J, Oberhauser F, Kornhuber J, Wiltfang J, et al
    Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls.
    PLoS One. 2018;13:e0197329.
    PubMed     Abstract available

  209. SALAMA M, Shalash A, Magdy A, Makar M, et al
    Tubulin and Tau: Possible targets for diagnosis of Parkinson's and Alzheimer's diseases.
    PLoS One. 2018;13:e0196436.
    PubMed     Abstract available

  210. LEE S, Zimmerman ME, Narkhede A, Nasrabady SE, et al
    White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease.
    PLoS One. 2018;13:e0195838.
    PubMed     Abstract available

  211. HIGAKI S, Muramatsu M, Matsuda A, Matsumoto K, et al
    Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models.
    PLoS One. 2018;13:e0196929.
    PubMed     Abstract available

  212. ZHENG W, Su Z, Liu X, Zhang H, et al
    Modulation of functional activity and connectivity by acupuncture in patients with Alzheimer disease as measured by resting-state fMRI.
    PLoS One. 2018;13:e0196933.
    PubMed     Abstract available

  213. ULBRICH S, Janning P, Seidel R, Matschke J, et al
    Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease.
    PLoS One. 2018;13:e0197659.
    PubMed     Abstract available

  214. MATSUSHITA M, Yatabe Y, Koyama A, Katsuya A, et al
    Are saving appearance responses typical communication patterns in Alzheimer's disease?
    PLoS One. 2018;13:e0197468.
    PubMed     Abstract available

  215. LASHKARI K, Teague G, Chen H, Lin YQ, et al
    A monoclonal antibody targeting amyloid beta (Abeta) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease.
    PLoS One. 2018;13:e0195751.
    PubMed     Abstract available

  216. KOBAYASHI Y, Inagawa H, Kohchi C, Kazumura K, et al
    Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents metabolic dysfunction and Alzheimer's disease-related memory loss in senescence-accelerated prone 8 (SAMP8) mice fed a high-fat diet.
    PLoS One. 2018;13:e0198493.
    PubMed     Abstract available

  217. NYITRAI G, Spisak T, Spisak Z, Gajari D, et al
    Stepwise occlusion of the carotid arteries of the rat: MRI assessment of the effect of donepezil and hypoperfusion-induced brain atrophy and white matter microstructural changes.
    PLoS One. 2018;13:e0198265.
    PubMed     Abstract available

  218. MARSHALL MS, Jakubauskas B, Bogue W, Stoskute M, et al
    Analysis of age-related changes in psychosine metabolism in the human brain.
    PLoS One. 2018;13:e0193438.
    PubMed     Abstract available

  219. ZHANG Y, Lin C, Zhang L, Cui Y, et al
    Correction: Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial.
    PLoS One. 2018;13:e0199895.
    PubMed     Abstract available

  220. WOOD PL, Tippireddy S, Feriante J, Woltjer RL, et al
    Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease.
    PLoS One. 2018;13:e0191815.
    PubMed     Abstract available

  221. GOTZ A, Scharnagl C
    Dissecting conformational changes in APP's transmembrane domain linked to epsilon-efficiency in familial Alzheimer's disease.
    PLoS One. 2018;13:e0200077.
    PubMed     Abstract available

  222. HANE F, Augusta C, Bai O
    A hierarchical Bayesian model to predict APOE4 genotype and the age of Alzheimer's disease onset.
    PLoS One. 2018;13:e0200263.
    PubMed     Abstract available

  223. ESPARZA TJ, Gangolli M, Cairns NJ, Brody DL, et al
    Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls.
    PLoS One. 2018;13:e0200251.
    PubMed     Abstract available

  224. TISATO V, Zuliani G, Vigliano M, Longo G, et al
    Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.
    PLoS One. 2018;13:e0193867.
    PubMed     Abstract available

  225. DERKOW K, Rossling R, Schipke C, Kruger C, et al
    Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's disease.
    PLoS One. 2018;13:e0200602.
    PubMed     Abstract available

  226. CROFT CL, Moore BD, Ran Y, Chakrabarty P, et al
    Novel monoclonal antibodies targeting the microtubule-binding domain of human tau.
    PLoS One. 2018;13:e0195211.
    PubMed     Abstract available

  227. NEERGAARD JS, Dragsbaek K, Christiansen C, Karsdal MA, et al
    Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.
    PLoS One. 2018;13:e0194802.
    PubMed     Abstract available

  228. VERITE J, Page G, Paccalin M, Julian A, et al
    Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model.
    PLoS One. 2018;13:e0201232.
    PubMed     Abstract available

  229. DAYEH MA, Livadiotis G, Elaydi S
    A discrete mathematical model for the aggregation of beta-Amyloid.
    PLoS One. 2018;13:e0196402.
    PubMed     Abstract available

  230. MAAROUF CL, Walker JE, Sue LI, Dugger BN, et al
    Impaired hepatic amyloid-beta degradation in Alzheimer's disease.
    PLoS One. 2018;13:e0203659.
    PubMed     Abstract available

  231. FUROTANI K, Kamimura K, Yajima T, Nakayama M, et al
    Suppression of the synaptic localization of a subset of proteins including APP partially ameliorates phenotypes of the Drosophila Alzheimer's disease model.
    PLoS One. 2018;13:e0204048.
    PubMed     Abstract available

  232. HOARAU M, Malbert Y, Irague R, Hureau C, et al
    Correction: A Robust and Efficient Production and Purification Procedure of Recombinant Alzheimers Disease Methionine-Modified Amyloid-beta Peptides.
    PLoS One. 2018;13:e0205048.
    PubMed     Abstract available

  233. LEE J, Jung SJ, Choi JW, Shin A, et al
    Use of sedative-hypnotics and the risk of Alzheimer's dementia: A retrospective cohort study.
    PLoS One. 2018;13:e0204413.
    PubMed     Abstract available

  234. DONG X, Yan L, Huang L, Guan X, et al
    Repetitive transcranial magnetic stimulation for the treatment of Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2018;13:e0205704.
    PubMed     Abstract available

  235. Correction: Use of sedative-hypnotics and the risk of Alzheimer's dementia: A retrospective cohort study.
    PLoS One. 2018;13:e0206094.
    PubMed     Abstract available

  236. JIANG H, Newman M, Lardelli M
    The zebrafish orthologue of familial Alzheimer's disease gene PRESENILIN 2 is required for normal adult melanotic skin pigmentation.
    PLoS One. 2018;13:e0206155.
    PubMed     Abstract available

  237. ROCHON PA, Gruneir A, Bell CM, Savage R, et al
    Comparison of prescribing practices for older adults treated by female versus male physicians: A retrospective cohort study.
    PLoS One. 2018;13:e0205524.
    PubMed     Abstract available

  238. BARTHOLD D, Joyce G, Wharton W, Kehoe P, et al
    The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicity.
    PLoS One. 2018;13:e0206705.
    PubMed     Abstract available

  239. KATSEL P, Roussos P, Beeri MS, Gama-Sosa MA, et al
    Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer's disease and normalized by treatment with anti-diabetic agents.
    PLoS One. 2018;13:e0206547.
    PubMed     Abstract available

  240. ORIMAYE SO, Wong JS, Wong CP
    Deep language space neural network for classifying mild cognitive impairment and Alzheimer-type dementia.
    PLoS One. 2018;13:e0205636.
    PubMed     Abstract available

  241. OGAWA M, Sone D, Maruo K, Shimada H, et al
    Analysis of risk factors for mild cognitive impairment based on word list memory test results and questionnaire responses in healthy Japanese individuals registered in an online database.
    PLoS One. 2018;13:e0197466.
    PubMed     Abstract available

  242. MOSCONI L, Rahman A, Diaz I, Wu X, et al
    Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.
    PLoS One. 2018;13:e0207885.
    PubMed     Abstract available

  243. WATTS AS, Mortby ME, Burns JM
    Depressive symptoms as a barrier to engagement in physical activity in older adults with and without Alzheimer's disease.
    PLoS One. 2018;13:e0208581.
    PubMed     Abstract available

  244. HAGENAARS SP, Radakovic R, Crockford C, Fawns-Ritchie C, et al
    Genetic risk for neurodegenerative disorders, and its overlap with cognitive ability and physical function.
    PLoS One. 2018;13:e0198187.
    PubMed     Abstract available

  245. STUDNICKI M, Wozniak G, Stepkowski D
    Correction: The Calculator of Anti-Alzheimer's Diet. Macronutrients.
    PLoS One. 2018;13:e0209723.
    PubMed     Abstract available

  246. PAVONI S, Jarray R, Nassor F, Guyot AC, et al
    Small-molecule induction of Abeta-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.
    PLoS One. 2018;13:e0209150.
    PubMed     Abstract available

  247. CESPEDES MI, McGree J, Drovandi CC, Mengersen K, et al
    An efficient algorithm for estimating brain covariance networks.
    PLoS One. 2018;13:e0198583.
    PubMed     Abstract available

  248. ANDARZI GARGARI S, Barzegar A, Tarinejad A
    The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing beta-sheet conformation of monomeric Abeta17-42.
    PLoS One. 2018;13:e0199541.
    PubMed     Abstract available

  249. SATO S, Ueki M
    Fast score test with global null estimation regardless of missing genotypes.
    PLoS One. 2018;13:e0199692.
    PubMed     Abstract available

  250. EVANS S, Clarke D, Dowell NG, Tabet N, et al
    Using event-related fMRI to examine sustained attention processes and effects of APOE epsilon4 in young adults.
    PLoS One. 2018;13:e0198312.
    PubMed     Abstract available

  251. TAKASUGI N, Araya R, Kamikubo Y, Kaneshiro N, et al
    TMEM30A is a candidate interacting partner for the beta-carboxyl-terminal fragment of amyloid-beta precursor protein in endosomes.
    PLoS One. 2018;13:e0200988.
    PubMed     Abstract available

  252. LATULIPPE J, Lotito D, Murby D
    A mathematical model for the effects of amyloid beta on intracellular calcium.
    PLoS One. 2018;13:e0202503.
    PubMed     Abstract available

  253. LOBACH I, Sampson J, Alekseyenko A, Lobach S, et al
    Case-control studies of gene-environment interactions. When a case might not be the case.
    PLoS One. 2018;13:e0201140.
    PubMed     Abstract available

  254. JANG JW, Park JH, Kim S, Park YH, et al
    A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment.
    PLoS One. 2018;13:e0201852.
    PubMed     Abstract available

  255. MARINO S, Xu J, Zhao Y, Zhou N, et al
    Controlled feature selection and compressive big data analytics: Applications to biomedical and health studies.
    PLoS One. 2018;13:e0202674.
    PubMed     Abstract available

  256. OH ES, Blennow K, Bigelow GE, Inouye SK, et al
    Abnormal CSF amyloid-beta42 and tau levels in hip fracture patients without dementia.
    PLoS One. 2018;13:e0204695.
    PubMed     Abstract available

  257. ILIEVSKI V, Zuchowska PK, Green SJ, Toth PT, et al
    Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice.
    PLoS One. 2018;13:e0204941.
    PubMed     Abstract available

  258. DIEM AK, Carare RO, Weller RO, Bressloff NW, et al
    A control mechanism for intra-mural peri-arterial drainage via astrocytes: How neuronal activity could improve waste clearance from the brain.
    PLoS One. 2018;13:e0205276.
    PubMed     Abstract available

  259. BALLARINI NM, Rosenkranz GK, Jaki T, Konig F, et al
    Subgroup identification in clinical trials via the predicted individual treatment effect.
    PLoS One. 2018;13:e0205971.
    PubMed     Abstract available

  260. LIN W, Xie YC, Cheng PY, Dong LY, et al
    Association of visual hallucinations with very mild degenerative dementia due to dementia with Lewy bodies.
    PLoS One. 2018;13:e0205909.
    PubMed     Abstract available

  261. SIDDARTH P, Burggren AC, Merrill DA, Ercoli LM, et al
    Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding.
    PLoS One. 2018;13:e0208358.
    PubMed     Abstract available

    January 2017
  262. GAVIDIA-BOVADILLA G, Kanaan-Izquierdo S, Mataro-Serrat M, Perera-Lluna A, et al
    Early Prediction of Alzheimer's Disease Using Null Longitudinal Model-Based Classifiers.
    PLoS One. 2017;12:e0168011.
    PubMed     Abstract available

  263. PAPAZOGLOU A, Soos J, Lundt A, Wormuth C, et al
    Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice.
    PLoS One. 2017;12:e0169654.
    PubMed     Abstract available

  264. SONG Y, Kim HD, Lee MK, Hong IH, et al
    Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    PLoS One. 2017;12:e0169509.
    PubMed     Abstract available

  265. LI Y, Li Y, Li X, Zhang S, et al
    Head Injury as a Risk Factor for Dementia and Alzheimer's Disease: A Systematic Review and Meta-Analysis of 32 Observational Studies.
    PLoS One. 2017;12:e0169650.
    PubMed     Abstract available

  266. PAN X, Sang S, Fei G, Jin L, et al
    Enhanced Activities of Blood Thiamine Diphosphatase and Monophosphatase in Alzheimer's Disease.
    PLoS One. 2017;12:e0167273.
    PubMed     Abstract available

  267. MELLOTT TJ, Huleatt OM, Shade BN, Pender SM, et al
    Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
    PLoS One. 2017;12:e0170450.
    PubMed     Abstract available

  268. CAI K, Xu H, Guan H, Zhu W, et al
    Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices.
    PLoS One. 2017;12:e0170875.
    PubMed     Abstract available

  269. KASTANENKA KV, Hou SS, Shakerdge N, Logan R, et al
    Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's Disease.
    PLoS One. 2017;12:e0170275.
    PubMed     Abstract available

  270. MORIMOTO S, Takao M, Hatsuta H, Nishina Y, et al
    Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.
    PLoS One. 2017;12:e0171524.
    PubMed     Abstract available

  271. MIN LJ, Kobayashi Y, Mogi M, Tsukuda K, et al
    Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice.
    PLoS One. 2017;12:e0171515.
    PubMed     Abstract available

  272. COVA I, Pomati S, Maggiore L, Forcella M, et al
    Nutritional status and body composition by bioelectrical impedance vector analysis: A cross sectional study in mild cognitive impairment and Alzheimer's disease.
    PLoS One. 2017;12:e0171331.
    PubMed     Abstract available

  273. MORRIS JK, Vidoni ED, Johnson DK, Van Sciver A, et al
    Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial.
    PLoS One. 2017;12:e0170547.
    PubMed     Abstract available

  274. XU W, Liu J, Ma D, Yuan G, et al
    Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
    PLoS One. 2017;12:e0172477.
    PubMed     Abstract available

  275. SCHMIDT SA, Ording AG, Horvath-Puho E, Sorensen HT, et al
    Non-melanoma skin cancer and risk of Alzheimer's disease and all-cause dementia.
    PLoS One. 2017;12:e0171527.
    PubMed     Abstract available

  276. OGAMA N, Sakurai T, Nakai T, Niida S, et al
    Impact of frontal white matter hyperintensity on instrumental activities of daily living in elderly women with Alzheimer disease and amnestic mild cognitive impairment.
    PLoS One. 2017;12:e0172484.
    PubMed     Abstract available

  277. JI H, Wang Y, Liu G, Chang L, et al
    Elevated OPRD1 promoter methylation in Alzheimer's disease patients.
    PLoS One. 2017;12:e0172335.
    PubMed     Abstract available

  278. TOLPPANEN AM, Voutilainen A, Taipale H, Tanskanen A, et al
    Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011.
    PLoS One. 2017;12:e0173450.
    PubMed     Abstract available

  279. LONG X, Chen L, Jiang C, Zhang L, et al
    Prediction and classification of Alzheimer disease based on quantification of MRI deformation.
    PLoS One. 2017;12:e0173372.
    PubMed     Abstract available

  280. HOY AR, Ly M, Carlsson CM, Okonkwo OC, et al
    Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging.
    PLoS One. 2017;12:e0173982.
    PubMed     Abstract available

  281. MELLOTT TJ, Huleatt OM, Shade BN, Pender SM, et al
    Correction: Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
    PLoS One. 2017;12:e0174875.
    PubMed     Abstract available

  282. SON SJ, Kim J, Park H
    Structural and functional connectional fingerprints in mild cognitive impairment and Alzheimer's disease patients.
    PLoS One. 2017;12:e0173426.
    PubMed     Abstract available

  283. LIN TW, Chang CF, Chang YJ, Liao YH, et al
    Alzheimer's amyloid-beta A2T variant and its N-terminal peptides inhibit amyloid-beta fibrillization and rescue the induced cytotoxicity.
    PLoS One. 2017;12:e0174561.
    PubMed     Abstract available

  284. TU MC, Lo CP, Huang CF, Hsu YH, et al
    Effectiveness of diffusion tensor imaging in differentiating early-stage subcortical ischemic vascular disease, Alzheimer's disease and normal ageing.
    PLoS One. 2017;12:e0175143.
    PubMed     Abstract available

  285. VAN GIJSEL-BONNELLO M, Baranger K, Benech P, Rivera S, et al
    Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine.
    PLoS One. 2017;12:e0175369.
    PubMed     Abstract available

  286. KASAI T, Kondo M, Ishii R, Tanaka A, et al
    Abeta levels in the jugular vein and high molecular weight Abeta oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease.
    PLoS One. 2017;12:e0174630.
    PubMed     Abstract available

  287. YOSHINAGA T, Nishimata H, Kajiya Y, Yokoyama S, et al
    Combined assessment of serum folate and hemoglobin as biomarkers of brain amyloid beta accumulation.
    PLoS One. 2017;12:e0175854.
    PubMed     Abstract available

  288. HAAKSMA ML, Vilela LR, Marengoni A, Calderon-Larranaga A, et al
    Comorbidity and progression of late onset Alzheimer's disease: A systematic review.
    PLoS One. 2017;12:e0177044.
    PubMed     Abstract available

  289. VALLEJO V, Wyss P, Rampa L, Mitache AV, et al
    Evaluation of a novel Serious Game based assessment tool for patients with Alzheimer's disease.
    PLoS One. 2017;12:e0175999.
    PubMed     Abstract available

  290. TASCONE LDS, Payne ME, MacFall J, Azevedo D, et al
    Cortical brain volume abnormalities associated with few or multiple neuropsychiatric symptoms in Alzheimer's disease.
    PLoS One. 2017;12:e0177169.
    PubMed     Abstract available

  291. FANG J, Wang L, Li Y, Lian W, et al
    AlzhCPI: A knowledge base for predicting chemical-protein interactions towards Alzheimer's disease.
    PLoS One. 2017;12:e0178347.
    PubMed     Abstract available

  292. LV F, Yang X, Cui C, Su C, et al
    Exogenous expression of Drp1 plays neuroprotective roles in the Alzheimer's disease in the Abeta42 transgenic Drosophila model.
    PLoS One. 2017;12:e0176183.
    PubMed     Abstract available

    Age-dependent regulation of obesity and Alzheimer-related outcomes by hormone therapy in female 3xTg-AD mice.
    PLoS One. 2017;12:e0178490.
    PubMed     Abstract available

  294. LEE SE, Hyun H, Park MR, Choi Y, et al
    Production of transgenic pig as an Alzheimer's disease model using a multi-cistronic vector system.
    PLoS One. 2017;12:e0177933.
    PubMed     Abstract available

  295. KAZEMIFAR S, Manning KY, Rajakumar N, Gomez FA, et al
    Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease.
    PLoS One. 2017;12:e0178529.
    PubMed     Abstract available

  296. CHIU PY, Wang CW, Tsai CT, Li SH, et al
    Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease.
    PLoS One. 2017;12:e0179399.
    PubMed     Abstract available

  297. NEWMAN M, Halter L, Lim A, Lardelli M, et al
    Mitochondrion to endoplasmic reticulum apposition length in zebrafish embryo spinal progenitors is unchanged in response to perturbations associated with Alzheimer's disease.
    PLoS One. 2017;12:e0179859.
    PubMed     Abstract available

  298. BOWLES EJA, Walker RL, Anderson ML, Dublin S, et al
    Risk of Alzheimer's disease or dementia following a cancer diagnosis.
    PLoS One. 2017;12:e0179857.
    PubMed     Abstract available

  299. FANIA C, Arosio B, Capitanio D, Torretta E, et al
    Protein signature in cerebrospinal fluid and serum of Alzheimer's disease patients: The case of apolipoprotein A-1 proteoforms.
    PLoS One. 2017;12:e0179280.
    PubMed     Abstract available

  300. XING HY, Li B, Peng D, Wang CY, et al
    A novel monoclonal antibody against the N-terminus of Abeta1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    PLoS One. 2017;12:e0180076.
    PubMed     Abstract available

  301. MODI KK, Jana A, Ghosh S, Watson R, et al
    Correction: A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease.
    PLoS One. 2017;12:e0180602.
    PubMed     Abstract available

  302. HAN Z, Huang H, Gao Y, Huang Q, et al
    Functional annotation of Alzheimer's disease associated loci revealed by GWASs.
    PLoS One. 2017;12:e0179677.
    PubMed     Abstract available

  303. YU L, Lutz MW, Wilson RS, Burns DK, et al
    APOE epsilon4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
    PLoS One. 2017;12:e0180356.
    PubMed     Abstract available

  304. MASTROENI D, Sekar S, Nolz J, Delvaux E, et al
    ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.
    PLoS One. 2017;12:e0177814.
    PubMed     Abstract available

  305. KONG W, Mou X, Deng J, Di B, et al
    Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation.
    PLoS One. 2017;12:e0180337.
    PubMed     Abstract available

  306. GUAN C, Dang R, Cui Y, Liu L, et al
    Characterization of plasma metal profiles in Alzheimer's disease using multivariate statistical analysis.
    PLoS One. 2017;12:e0178271.
    PubMed     Abstract available

  307. ITOH Y, Voskuhl RR
    Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
    PLoS One. 2017;12:e0181349.
    PubMed     Abstract available

  308. ZHANG C, Rissman RA
    Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer's disease mice.
    PLoS One. 2017;12:e0181367.
    PubMed     Abstract available

  309. LLANO DA, Bundela S, Mudar RA, Devanarayan V, et al
    A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression.
    PLoS One. 2017;12:e0182098.
    PubMed     Abstract available

  310. DROLLE E, Negoda A, Hammond K, Pavlov E, et al
    Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease.
    PLoS One. 2017;12:e0182194.
    PubMed     Abstract available

  311. YASAR S, Jusue-Torres I, Lu J, Robison J, et al
    Alzheimer's disease pathology and shunt surgery outcome in normal pressure hydrocephalus.
    PLoS One. 2017;12:e0182288.
    PubMed     Abstract available

  312. PARK KW, Kim EJ, Han HJ, Shim YS, et al
    Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial.
    PLoS One. 2017;12:e0182123.
    PubMed     Abstract available

  313. FRUZANGOHAR M, Ebrahimie E, Adelson DL
    A novel hypothesis-unbiased method for Gene Ontology enrichment based on transcriptome data.
    PLoS One. 2017;12:e0170486.
    PubMed     Abstract available

  314. GOCH W, Bal W
    Numerical Simulations Reveal Randomness of Cu(II) Induced Abeta Peptide Dimerization under Conditions Present in Glutamatergic Synapses.
    PLoS One. 2017;12:e0170749.
    PubMed     Abstract available

  315. ARRAZOLA MS, Ramos-Fernandez E, Cisternas P, Ordenes D, et al
    Wnt Signaling Prevents the Abeta Oligomer-Induced Mitochondrial Permeability Transition Pore Opening Preserving Mitochondrial Structure in Hippocampal Neurons.
    PLoS One. 2017;12:e0168840.
    PubMed     Abstract available

  316. BARTEL F, Vrenken H, Bijma F, Barkhof F, et al
    Regional analysis of volumes and reproducibilities of automatic and manual hippocampal segmentations.
    PLoS One. 2017;12:e0166785.
    PubMed     Abstract available

  317. SERRANO-POZO A, Sanchez-Garcia MA, Heras-Garvin A, March-Diaz R, et al
    Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-beta Peptide Generation In Vivo.
    PLoS One. 2017;12:e0170345.
    PubMed     Abstract available

  318. LIANG J, Kulasiri D, Samarasinghe S
    Computational investigation of Amyloid-beta-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer's disease.
    PLoS One. 2017;12:e0182743.
    PubMed     Abstract available

  319. VAN KAMPEN JM, Kay DG
    Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer's disease.
    PLoS One. 2017;12:e0182896.
    PubMed     Abstract available

  320. WANG H, Williams D, Griffin J, Saito T, et al
    Time-course global proteome analyses reveal an inverse correlation between Abeta burden and immunoglobulin M levels in the APPNL-F mouse model of Alzheimer disease.
    PLoS One. 2017;12:e0182844.
    PubMed     Abstract available

  321. CHEN R, Chan PT, Chu H, Lin YC, et al
    Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis.
    PLoS One. 2017;12:e0183586.
    PubMed     Abstract available

  322. SHI JM, Pei J, Liu EQ, Zhang L, et al
    Bis(sulfosuccinimidyl) suberate (BS3) crosslinking analysis of the behavior of amyloid-beta peptide in solution and in phospholipid membranes.
    PLoS One. 2017;12:e0173871.
    PubMed     Abstract available

  323. LI T, Xie Y, Bowe B, Xian H, et al
    Serum phosphorus levels and risk of incident dementia.
    PLoS One. 2017;12:e0171377.
    PubMed     Abstract available

  324. LI T, Li W, Yang Y, Zhang W, et al
    Classification of brain disease in magnetic resonance images using two-stage local feature fusion.
    PLoS One. 2017;12:e0171749.
    PubMed     Abstract available

  325. PARK HY, Park JW, Song HJ, Sohn HS, et al
    The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea.
    PLoS One. 2017;12:e0169463.
    PubMed     Abstract available

  326. NICHOLLS SB, DeVos SL, Commins C, Nobuhara C, et al
    Characterization of TauC3 antibody and demonstration of its potential to block tau propagation.
    PLoS One. 2017;12:e0177914.
    PubMed     Abstract available

  327. JOHANSSON P, Almqvist EG, Wallin A, Johansson JO, et al
    Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.
    PLoS One. 2017;12:e0176760.
    PubMed     Abstract available

  328. JOE IS, Kim JH, Kim H, Hong JH, et al
    Cyclin Y-mediated transcript profiling reveals several important functional pathways regulated by Cyclin Y in hippocampal neurons.
    PLoS One. 2017;12:e0172547.
    PubMed     Abstract available

  329. LIU T, Lee M, Ban JJ, Im W, et al
    Cytosolic Extract of Human Adipose Stem Cells Reverses the Amyloid Beta-Induced Mitochondrial Apoptosis via P53/Foxo3a Pathway.
    PLoS One. 2017;12:e0168859.
    PubMed     Abstract available

  330. LIN HC, Xirasagar S, Lee HC, Huang CC, et al
    Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder.
    PLoS One. 2017;12:e0179312.
    PubMed     Abstract available

  331. CHUNG MC, Yu TM, Shu KH, Wu MJ, et al
    Hyponatremia and increased risk of dementia: A population-based retrospective cohort study.
    PLoS One. 2017;12:e0178977.
    PubMed     Abstract available

  332. TUGAEVA KV, Tsvetkov PO, Sluchanko NN
    Bacterial co-expression of human Tau protein with protein kinase A and 14-3-3 for studies of 14-3-3/phospho-Tau interaction.
    PLoS One. 2017;12:e0178933.
    PubMed     Abstract available

  333. AKHTAR RS, Xie SX, Chen YJ, Rick J, et al
    Regional brain amyloid-beta accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia.
    PLoS One. 2017;12:e0177924.
    PubMed     Abstract available

  334. SVARD D, Nilsson M, Lampinen B, Latt J, et al
    The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer's disease.
    PLoS One. 2017;12:e0185239.
    PubMed     Abstract available

  335. HAN F, Zhuang TT, Chen JJ, Zhu XL, et al
    Novel derivative of Paeonol, Paeononlsilatie sodium, alleviates behavioral damage and hippocampal dendritic injury in Alzheimer's disease concurrent with cofilin1/phosphorylated-cofilin1 and RAC1/CDC42 alterations in rats.
    PLoS One. 2017;12:e0185102.
    PubMed     Abstract available

  336. KHAYER N, Marashi SA, Mirzaie M, Goshadrou F, et al
    Three-way interaction model to trace the mechanisms involved in Alzheimer's disease transgenic mice.
    PLoS One. 2017;12:e0184697.
    PubMed     Abstract available

  337. RAHMAN A, Lamberty Y, Schenker E, Cella M, et al
    Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus).
    PLoS One. 2017;12:e0184822.
    PubMed     Abstract available

  338. SHENG C, Xia M, Yu H, Huang Y, et al
    Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment.
    PLoS One. 2017;12:e0179823.
    PubMed     Abstract available

  339. DANZIGER SA, Miller LR, Singh K, Whitney GA, et al
    An indicator cell assay for blood-based diagnostics.
    PLoS One. 2017;12:e0178608.
    PubMed     Abstract available

  340. MABROUK R, Strafella AP, Knezevic D, Ghadery C, et al
    Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function.
    PLoS One. 2017;12:e0177785.
    PubMed     Abstract available

  341. CHERRY JD, Stein TD, Tripodis Y, Alvarez VE, et al
    CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease.
    PLoS One. 2017;12:e0185541.
    PubMed     Abstract available

  342. WU YH, Vidal JS, de Rotrou J, Sikkes SAM, et al
    Can a tablet-based cancellation test identify cognitive impairment in older adults?
    PLoS One. 2017;12:e0181809.
    PubMed     Abstract available

  343. PERSYN E, Karakachoff M, Le Scouarnec S, Le Clezio C, et al
    DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease.
    PLoS One. 2017;12:e0179364.
    PubMed     Abstract available

  344. YI D, Seo EH, Han JY, Sohn BK, et al
    Development of the Korean Adult Reading Test (KART) to estimate premorbid intelligence in dementia patients.
    PLoS One. 2017;12:e0181523.
    PubMed     Abstract available

  345. MIKI STEIN A, Munive V, Fernandez AM, Nunez A, et al
    Acute exercise does not modify brain activity and memory performance in APP/PS1 mice.
    PLoS One. 2017;12:e0178247.
    PubMed     Abstract available

  346. REHKER J, Rodhe J, Nesbitt RR, Boyle EA, et al
    Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants.
    PLoS One. 2017;12:e0185777.
    PubMed     Abstract available

  347. CHAN YC, Hwang JH
    Effects of Spirulina on the functions and redox status of auditory system in senescence-accelerated prone-8 mice.
    PLoS One. 2017;12:e0178916.
    PubMed     Abstract available

  348. MOSCONI L, Berti V, Guyara-Quinn C, McHugh P, et al
    Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.
    PLoS One. 2017;12:e0185926.
    PubMed     Abstract available

  349. MATONE A, Derlindati E, Marchetti L, Spigoni V, et al
    Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects.
    PLoS One. 2017;12:e0182559.
    PubMed     Abstract available

  350. MIJALKOV M, Kakaei E, Pereira JB, Westman E, et al
    BRAPH: A graph theory software for the analysis of brain connectivity.
    PLoS One. 2017;12:e0178798.
    PubMed     Abstract available

  351. PERSSON K, Eldholm RS, Barca ML, Cavallin L, et al
    MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis.
    PLoS One. 2017;12:e0186595.
    PubMed     Abstract available

  352. ANASTASIOU CA, Yannakoulia M, Kosmidis MH, Dardiotis E, et al
    Mediterranean diet and cognitive health: Initial results from the Hellenic Longitudinal Investigation of Ageing and Diet.
    PLoS One. 2017;12:e0182048.
    PubMed     Abstract available

  353. SOLDNER CA, Sticht H, Horn AHC
    Role of the N-terminus for the stability of an amyloid-beta fibril with three-fold symmetry.
    PLoS One. 2017;12:e0186347.
    PubMed     Abstract available

  354. PARK HJ, Ryu D, Parmar M, Giasson BI, et al
    The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome.
    PLoS One. 2017;12:e0184262.
    PubMed     Abstract available

  355. YI B, Jahangir A, Evans AK, Briggs D, et al
    Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders.
    PLoS One. 2017;12:e0180319.
    PubMed     Abstract available

  356. YAO X, Yan J, Ginda M, Borner K, et al
    Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer's disease neuroimaging initiative.
    PLoS One. 2017;12:e0186095.
    PubMed     Abstract available

  357. MIHELCIC M, Simic G, Babic Leko M, Lavrac N, et al
    Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients.
    PLoS One. 2017;12:e0187364.
    PubMed     Abstract available

  358. CHIU PY, Hsu MH, Wang CW, Tsai CT, et al
    Visual hallucinations in Alzheimer's disease is significantly associated with clinical diagnostic features of dementia with Lewy bodies.
    PLoS One. 2017;12:e0186886.
    PubMed     Abstract available

  359. RASERO J, Amoroso N, La Rocca M, Tangaro S, et al
    Multivariate regression analysis of structural MRI connectivity matrices in Alzheimer's disease.
    PLoS One. 2017;12:e0187281.
    PubMed     Abstract available

  360. HOHMAN TJ, Dumitrescu L, Oksol A, Wagener M, et al
    APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease.
    PLoS One. 2017;12:e0188501.
    PubMed     Abstract available

  361. RUDOBECK E, Bellone JA, Szucs A, Bonnick K, et al
    Low-dose proton radiation effects in a transgenic mouse model of Alzheimer's disease - Implications for space travel.
    PLoS One. 2017;12:e0186168.
    PubMed     Abstract available

  362. CHU TH, Cummins K, Sparling JS, Tsutsui S, et al
    Axonal and myelinic pathology in 5xFAD Alzheimer's mouse spinal cord.
    PLoS One. 2017;12:e0188218.
    PubMed     Abstract available

  363. OTTOY J, Verhaeghe J, Niemantsverdriet E, Engelborghs S, et al
    A simulation study on the impact of the blood flow-dependent component in [18F]AV45 SUVR in Alzheimer's disease.
    PLoS One. 2017;12:e0189155.
    PubMed     Abstract available

  364. WANG L, Hubbard RA, Walker RL, Lee EB, et al
    Assessing robustness of hazard ratio estimates to outcome misclassification in longitudinal panel studies with application to Alzheimer's disease.
    PLoS One. 2017;12:e0190107.
    PubMed     Abstract available

  365. ELNAGAR MR, Walls AB, Helal GK, Hamada FM, et al
    Probing the putative alpha7 nAChR/NMDAR complex in human and murine cortex and hippocampus: Different degrees of complex formation in healthy and Alzheimer brain tissue.
    PLoS One. 2017;12:e0189513.
    PubMed     Abstract available

  366. WEED MR, Polino J, Signor L, Bookbinder M, et al
    Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
    PLoS One. 2017;12:e0187609.
    PubMed     Abstract available

  367. ASAM K, Staniszewski A, Zhang H, Melideo SL, et al
    Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid.
    PLoS One. 2017;12:e0189413.
    PubMed     Abstract available

  368. MONTOLIU-GAYA L, Mulder SD, Veerhuis R, Villegas S, et al
    Effects of an Abeta-antibody fragment on Abeta aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
    PLoS One. 2017;12:e0188191.
    PubMed     Abstract available

  369. HA S, Kim I, Takata T, Kinouchi T, et al
    Identification of -amino acid-containing peptides in human serum.
    PLoS One. 2017;12:e0189972.
    PubMed     Abstract available

    January 2016
  370. RAJA WK, Mungenast AE, Lin YT, Ko T, et al
    Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.
    PLoS One. 2016;11:e0161969.
    PubMed     Abstract available

  371. CHEN PT, Chen CL, Lin LT, Lo CH, et al
    Design of Peptide Substrate for Sensitively and Specifically Detecting Two Abeta-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
    PLoS One. 2016;11:e0153360.
    PubMed     Abstract available

  372. SU Y, Blazey TM, Owen CJ, Christensen JJ, et al
    Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.
    PLoS One. 2016;11:e0163669.
    PubMed     Abstract available

  373. LEE HK, Velazquez Sanchez C, Chen M, Morin PJ, et al
    Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells.
    PLoS One. 2016;11:e0163072.
    PubMed     Abstract available

  374. BAEK MJ, Kim K, Park YH, Kim S, et al
    The Validity and Reliability of the Mini-Mental State Examination-2 for Detecting Mild Cognitive Impairment and Alzheimer's Disease in a Korean Population.
    PLoS One. 2016;11:e0163792.
    PubMed     Abstract available

  375. CORREA MS, Giacobbo BL, Vedovelli K, Lima DB, et al
    Age Effects on Cognitive and Physiological Parameters in Familial Caregivers of Alzheimer's Disease Patients.
    PLoS One. 2016;11:e0162619.
    PubMed     Abstract available

  376. SASAOKA S, Matsui T, Hane Y, Abe J, et al
    Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events.
    PLoS One. 2016;11:e0164309.
    PubMed     Abstract available

  377. MORRONE CD, Thomason LA, Brown ME, Aubert I, et al
    Effects of Neurotrophic Support and Amyloid-Targeted Combined Therapy on Adult Hippocampal Neurogenesis in a Transgenic Model of Alzheimer's Disease.
    PLoS One. 2016;11:e0165393.
    PubMed     Abstract available

  378. VISHNU VY, Modi M, Sharma S, Mohanty M, et al
    Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern India.
    PLoS One. 2016;11:e0166369.
    PubMed     Abstract available

  379. CERMAK S, Kosicek M, Mladenovic-Djordjevic A, Smiljanic K, et al
    Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.
    PLoS One. 2016;11:e0167428.
    PubMed     Abstract available

  380. DAMMERS C, Yolcu D, Kukuk L, Willbold D, et al
    Selection and Characterization of Tau Binding -Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease.
    PLoS One. 2016;11:e0167432.
    PubMed     Abstract available

  381. ZHANG M, Schmitt-Ulms G, Sato C, Xi Z, et al
    Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
    PLoS One. 2016;11:e0168812.
    PubMed     Abstract available

  382. KAO LT, Kang JH, Lin HC, Huang CC, et al
    Rheumatoid Arthritis Was Negatively Associated with Alzheimer's Disease: A Population-Based Case-Control Study.
    PLoS One. 2016;11:e0168106.
    PubMed     Abstract available

  383. STUDNICKI M, Wozniak G, Stepkowski D
    The Calculator of Anti-Alzheimer's Diet. Macronutrients.
    PLoS One. 2016;11:e0168385.
    PubMed     Abstract available

  384. KOBAYASHI N, Shinagawa S, Nagata T, Shimada K, et al
    Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    PLoS One. 2016;11:e0168816.
    PubMed     Abstract available

  385. PEREZ C, Ziburkus J, Ullah G
    Analyzing and Modeling the Dysfunction of Inhibitory Neurons in Alzheimer's Disease.
    PLoS One. 2016;11:e0168800.
    PubMed     Abstract available

  386. KRUSE N, Schlossmacher MG, Schulz-Schaeffer WJ, Vanmechelen E, et al
    A First Tetraplex Assay for the Simultaneous Quantification of Total alpha-Synuclein, Tau, beta-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
    PLoS One. 2016;11:e0153564.
    PubMed     Abstract available

  387. LIANG CT, Huang HB, Wang CC, Chen YR, et al
    L17A/F19A Substitutions Augment the alpha-Helicity of beta-Amyloid Peptide Discordant Segment.
    PLoS One. 2016;11:e0154327.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.